We use mouse models to study neurological disorders such as epilepsy, autism, and AD. We also work on disease gene discovery and treatment development.
We're looking for motivated postdocs that are passionate about studying epilepsy and other neurological disorders! Check out our website and come join us in awesome Atlanta! https://t.co/tGy2gwzuVT
We're looking for motivated postdocs that are passionate about studying epilepsy and other neurological disorders! Check out our website and come join us in awesome Atlanta! https://t.co/tGy2gwzuVT
Happening soon! Stop by posters from the @EscaygLab! 1.002 effect of status epilepticus on brain extracellular vesicles and 1.053 to hear about increased SCN8A activity in AD! 🤓 The Escayg laboratory is also recruiting post docs, so come by and meet us!
Stop by posters from @EscaygLab tomorrow! 1.002 effect of status epilepticus on brain extracellular vesicles and 1.053 to hear about increased SCN8A activity in AD! 🤓 We’ll be there from 12-2!
Excited for #AES2023! Stop by my poster 1.053 on Saturday to hear more about the detrimental effects of increased SCN8A activity in Alzheimer’s disease!
Excited and grateful for the opportunity to present our work on treatment development in SCN8A-derived epilepsy this evening at the SCN8A Gathering! @EscaygLab@TheCuteSyndrome@DEE_Pconnection
We show that lack of full-length ADGRB3 results in reduced brain/body weight ratio and impaired social interaction! Congrats on another 1st author paper, Thomas! @thomasShiu1 https://t.co/dfY2nHiOoa
Stop by poster 2.335 today to hear about our functional characterization of ATP6V0C! Tomorrow, come by 3.277 to see the latest work on our nanoparticle-encapsulated NPY formulation!
We're at #AES2022! Let us know if you want to meet up! Come check out the latest work from the Escayg lab: posters 1.059 (BCL11A), 2.335 (ATP6V0C), and 3.277 (nanoparticle-encapsulated NPY)!
We are recruiting postdocs for our neurogenetics laboratory! We will be at #AES2022. If you will be in Nashville, please reach out to us and we will be happy to meet. For more information: https://t.co/9y5CR0n216